Why Attend?

Agenda
Location & CLE

The premier conference for the food and drug law community, the FDLI Annual Conference addresses complex legal, regulatory, compliance, and policy issues in all facets of the FDA-regulated industry. The two-day event provides in-depth discussions and analyses on a wide variety of timely topics by bringing together experts from the federal government, industry, the private bar, non-profits, patient and consumer advocates, consulting organizations, and academia.

Keynote Address: Norman E. Sharpless, Acting Commissioner of Food and Drugs, FDA.

 

 

Conference Highlights:

  • Hear FDA’s 2019 strategic priorities directly from the FDA Commissioner, Chief Counsel, Center Directors, and other key leaders within the Agency
  • Join more than 900 high-level colleagues in food and drug law to hear different viewpoints, shape policy, and advance understanding
  • Select from nearly 30 breakout sessions covering the latest in legal, regulatory, compliance, policy, marketing, and related issues
  • Learn from more than 100 well-known officials and experts
  • Hear about the Top Cases in Food and Drug Law
  • Network and build relationships with seasoned law, regulatory, compliance, marketing/advertising, and management professionals

Premier Sponsor

Diamond Sponsor

Diamond Sponsor

Gold Sponsor

Gold Sponsor

Gold Sponsor

Gold Sponsor

Gold Sponsor

Gold Sponsor

Gold Sponsor

Silver Sponsor

Silver Sponsor

Silver Sponsor

Silver Sponsor

Silver Sponsor

Silver Sponsor

Silver Sponsor

Bronze Sponsor

Planning Committee

Co-Chairs

Amy Norris
Chief Counsel, Clif Bar & Company

William Schultz
Partner, Zuckerman Spaeder LLP

Committee Members

Azim Chowdhury, Partner, Keller and Heckman LLP
Dean R. Cirotta, President & COO, EAS Consulting Group, LLC
James N. Czaban, Partner, DLA Piper LLP
Kathleen Hoke, Professor & Director, Network for Public Health Policy and Center for Tobacco Regulation,
University of Maryland Carey School of Law
Brenda Huneycutt, Director, Regulatory Innovation, FasterCures
Madeleine M. McDonough, Partner and Chair, Shook, Hardy & Bacon LLP
John A. Murphy, Deputy General Counsel, Biotechnology Innovation Organization
Adora Ndu, Executive Director, Regulatory Policy, Research & Engagement, BioMarin Pharmaceutical Inc.
Vernessa Pollard, Partner, McDermott Will & Emery
Stuart Pape, Shareholder, Polsinelli PC
Cassie Scherer, Principal Legal Counsel, Corporate Legal Regulatory, Medtronic
Jesse J. Sevcik, Sr. Director, Global Government Affairs, Elanco Animal Health
Julia (Julie) Tierney, Senior Policy Advisor for Strategic Planning and Legislation, CBER, FDA
Michael Werner, Partner, Holland & Knight LLP
José Alberto Campos Vargas, Partner, Sánchez Devanny